Diabetic Medicine

Validation of an algorithm combining haemoglobin A_1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations
pp. 115-121(7)
Authors: Manley, S. E.; Sikaris, K. A.; Lu, Z. X.; Nightingale, P. G.; Stratton, I. M.; Round, R. A.; Baskar, V.; Gough, S. C. L.; Smith, J. M.

HbA_1c levels in non-diabetic Dutch children aged 8-9 years: the PIAMA birth cohort study
pp. 122-127(6)
Authors: Jansen, H.; Wijga, A. H.; Smit, H. A.; Scholtens, S.; Kerkhof, M.; Koppelman, G. H.; de Jongste, J. C.; Stolk, R. P.

Ethnic variation in the correlation between random serum glucose concentration and glycated haemoglobin
pp. 128-133(6)
Authors: Bleyer, A. J.; Hire, D.; Russell, G. B.; Xu, J.; Divers, J.; Shihabi, Z.; Bowden, D. W.; Freedman, B. I.

Complications impaired endothelial progenitor cell function in Type 2 diabetic patients with or without critical leg ischaemia: implication for impaired neovascularization in diabetes
pp. 134-141(8)
Authors: Chen, M.-C.; Sheu, J.-J.; Wang, P.-W.; Chen, C.-Y.; Kuo, M.-C.; Hsieh, C.-J.; Chen, J.-F.; Chang, H.-W.

Is diabetes a coronary risk equivalent? Systematic review and meta-analysis
pp. 142-148(7)
Authors: Bulugahapitiya, U.; Siyambalapitiya, S.; Sithole, J.; Idris, I.

Serological evidence of infections and Type 2 diabetes: the Multiethnic Study of Atherosclerosis
pp. 149-152(4)
Authors: Lutsey, P. L.; Pankow, J. S.; Bertoni, A. G.; Szklo, M.; Folsom, A. R.

Anxiety and depression symptoms in patients with diabetes
pp. 153-161(9)
Authors: Collins, M. M.; Corcoran, P.; Perry, I. J.

The transition from children's to adult diabetes services: understanding the `problem'
pp. 162-166(5)
Authors: Allen, D.; Gregory, J.

Continuous glucose monitoring as a tool to identify hyperglycaemia in non-diabetic patients with acute coronary syndromes
pp. 167-170(4)
Authors: Radermecker, R. P.; Sultan, A.; Piot, C.; Remy, A. S.; Avignon, A.; Renard, E.

Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy
pp. 171-173(3)
Authors: Makino, H.; Okada, S.; Nagumo, A.; Sugisawa, T.; Miyamoto, Y.; Kishimoto, I.; Kikuchi-Taura, A.; Soma, T.; Taguchi, A.; Yoshimasa, Y.

Effect of insulin infusion on electrocardiographic findings following acute myocardial infarction: importance of glycaemic control
pp. 174-176(3)
Authors: Gan, R. M.; Wong, V.; Cheung, N. W.; McLean, M.

Insulin resistance is an independent correlate of increased urine albumin excretion: a cross-sectional study in Iranian Type 2 diabetic patients
pp. 177-181(5)
Authors: Esteghamati, A.; Ashraf, H.; Nakhjavani, M.; Najafian, B.; Hamidi, S.; Abbasi, M.

Elevated plasma prostaglandins and acetylated histone in monocytes in Type 1 diabetes patients
pp. 182-186(5)
Authors: Chen, S. S. H.; Jenkins, A. J.; Majewski, H.

Miglitol induces prolonged and enhanced glucagon-like peptide-1 and reduced gastric inhibitory polypeptide responses after ingestion of a mixed meal in Japanese Type 2 diabetic patients
pp. 187-188(2)
Authors: Narita, T.; Katsuura, Y.; Sato, T.; Hosoba, M.; Fujita, H.; Morii, T.; Yamada, Y.

Treatment of HNF1-alpha MODY with the DPP-4 inhibitor Sitagliptin
pp. 189-190(2)
Authors: Lumb, Alistair N.; Gallen, Ian W.

A dramatic deterioration in diabetic retinopathy with improvement in glycated haemoglobin (HbA_1c) on exenatide treatment
pp. 190-190(1)
Authors: Brooks, A. M. S.; Lissett, C. A.

Driving and diabetes: DVLA response to Lonnen et al.
pp. 191-191(1)
Authors: Major, H. G.; Rees, S. D. R.; Frier, B. M.

Psychosocial distress predicts diabetes: is additional research warranted?
pp. 191-192(2)
Authors: Jorgensen, R. S.; Smyth, J. M.

Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. But what about the amiodarone?
pp. 192-193(2)
Author: Boucher, B. J.